◆Korea Financial Group=Subsidiary of Korea Investment Accelerator Incorporated


◆Daehan Petrochemical=Decision to increase short-term borrowing limit by 100 billion KRW


◆SK Biopharm=Supply contract worth 1.7 billion KRW with US local subsidiary for epilepsy treatment new drug Cenobamate sales in the US market



◆Dongseo=Cash dividend of 700 KRW per common share decided...Total amount of 69.1 billion KRW


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing